Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15518-15531
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15518
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15518
Ref. | Animal model | Probiotic | Weeks | Positive effects | Negative effects |
Li et al[63] | HFD ob/ob mice | VSL#3 | 4 | Reduced liver inflammation and serum ALT | |
Esposito et al[64] | HFD Sprague-Dawley rats | VSL#3 | 4 | Significantly reduced TNF alpha levels, MMP-2 and MMP-9 activities, iNOS, and Cox-2 expression. Increased PPAR-alpha expression | NS |
Ma et al[65] | HFD-WT male C57BL6 | VSL#3 | 4 | Improved NKT cells depletion, insulin resistance, and hepatic steatosis | NS |
Velayudham et al[66] | MCD mouse | VSL#3 | 10 | Prevented PPAR-induced fibrosis. Increased expression of Bambi, a negative regulator of the TGFβ signaling pathway | Did not prevent NASH. |
Did not protect against MCD liver injury | |||||
Mencarelli et al[67] | Apo E-/- mice fed dextran sulfate sodium | VSL#3 | 12 | Reversed IR and prevented steatohepatitis by transactivation of PPARγ | NS |
Bhathena et al[68] | MCD Bio F1B Golden Syrian hamster | Lactobacillus fermentum ATCC | 12 | Reduced liver fat deposition, decreased total cholesterol, triglycerides, uric acid, and insulin resistance | NS |
Wagnerberger et al[69] | High fructose intake C57BL/6 L mouse | Lactobacillus Casei-Shirota | 8 | Attenuated the TLR4 signaling pathway and increased PPAR activity | |
Karahan et al[70] | MCD Wistar rats | Pro1; Pro2 | 2 and 8 | Both probiotics reduced ≥ 50% the incidence of steatohepatitis by modulating apoptosis + anti-inflammatory activity | NS |
Yalçin et al[71] | Broilers fed low-protein diet | Primalac 454 | 4 | Significantly diminished histological grade, steatosis and cell ballooning scores | Increased serum TG |
Xu et al[72] | HFD Sprague-Dawley rats | Lactobacillus acidophilus Bifidobacterium longum | 12 | Bifidobacterium longum was superior to Lactobacillus acidophilus in attenuating liver fat accumulation. No variation of intestinal permeability in the treated groups | |
Nardone et al[74] | Ischemia/reperfusion (I/R) in rats fed a standard or MCD diet | Lactobacillus Paracasei | 8 | Reduced LPS levels. Attenuated I/R-related damage | NS |
Fazeli et al[75] | Rats on high cholesterol diet | Lactobacillus plantarum A7 | 2 | Significantly reduced levels of cholesterol, TG and LDL | NS |
Endo et al[77] | Male Fischer CDAA rats | Butyrate producing Clostridium butyricum MIYAIRI 588 | 8, 16, 50 | Delayed CDAA-induced NAFLD progression and liver tumorigenesis. Reduced lipid deposition and improved IR, serum endotoxin levels, and hepatic inflammatory indexes. Improved ZO-1 expression | NS |
Chiua et al[78] | HepG2 cells exposed to LPS | Lactobacilli bacteria lisate | Suppressed cytokine signaling 1 and PPAR alpha via NOD-NF-κB and cross-regulation of TLR4 | NS | |
Raso et al[76] | Rats on a HFD | Synbiotic with Lactobacillus paracasei B21060 | 6 | Improved IR parametersReduced cytokine synthesis and restored the HFD-dysregulated TLR 2, 4 and 9 mRNAs.Preserved gut barrier integrity | NS |
- Citation: Paolella G, Mandato C, Pierri L, Poeta M, Di Stasi M, Vajro P. Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(42): 15518-15531
- URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15518.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15518